Evaluation Of The Effect Of Spinal Orthosis On Tactile Sense And Balance In Individuals With Lumbal Curve And Adolescent Idiopathic Scoliosis
Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Dec 6, 2023
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how wearing a special back brace, called a spinal orthosis, affects the sense of touch and balance in teenagers with a specific type of scoliosis known as Adolescent Idiopathic Scoliosis (AIS). The researchers believe that wearing the brace for at least 20 hours a day can help improve the curvature of the spine and may also influence how sensitive the skin is in the areas affected by the curve. They want to understand how these changes relate to balance, body fat, and any pain experienced by the participants.
To be eligible for the trial, participants should be between the ages of 10 and 18, have a lumbar curvature between 20-45 degrees, and have never worn a spinal brace before. Participants will be closely monitored during the study, and they can expect to undergo sensory testing and assessments of their balance while using the spinal orthosis. This study aims to gather more information about how spinal braces can help young people with scoliosis, as there is currently limited research in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being diagnosed with Adolescent Idiopathic Scoliosis (AIS) between the ages of 10-18,
- • Curvature only in the lumbar region,
- • 20-45 degree curvature degree,
- • Being deemed suitable for spinal orthosis use by the doctor,
- • Not having used a spinal orthosis before
- Exclusion Criteria:
- • Having different diagnoses such as congenital scoliosis, spina bfida, traumatic scoliosis, osteoporosis,
- • Having had spine surgery
- • Having used a scoliosis spinal orthosis,
- • Having an accompanying disease that may prevent the use of spinal orthosis and
- • Failure to sign the consent form required to participate in the study
About Istanbul Medipol University Hospital
Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Basak Iscioglu
Principal Investigator
Medipol University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported